KEGG: sfl:SF2812
Xin antibody targets the protein encoded by the XIRP1 gene (xin actin binding repeat containing 1), also known as cardiomyopathy-associated protein 1. This protein is a critical component in the maintenance of cardiac and skeletal muscle structure. The human version of Xin has a canonical amino acid length of 1843 residues and a protein mass of 198.6 kilodaltons, with 3 identified isoforms . Xin antibody enables researchers to detect and measure the Xin antigen in biological samples, primarily for studying muscle development and function.
Xin protein is predominantly expressed in cardiac and skeletal muscle tissues, with particularly notable expression in heart muscle. At the cellular level, Xin is localized to cell junctions, specifically at adherens junctions and desmosomes . It colocalizes with actin stress fibers and is expressed at intercalated disks in cardiomyocytes of the heart. During myocyte differentiation, Xin localizes to actin filaments prior to differentiation and is then expressed at nonstriated nascent myofibrils and Z-bodies during the differentiation process .
Xin protein serves several critical functions in muscle physiology:
Required for maintaining correct cardiac intercalated disk ultrastructure through cell-cell adhesion stability
Maintains cardiac organ morphology, conductance, and heart beat rhythm
Essential for normal skeletal muscle morphology and muscle fiber type composition
Regulates muscle satellite cell activation and survival
While Xin antibody targets the XIRP1 gene product, Xnp antibody targets a completely different protein - the ATRX chromatin remodeler encoded by the ATRX gene. The human version of Xnp has a canonical amino acid length of 2492 residues and a protein mass of 282.6 kilodaltons (6 isoforms). Xnp functions in chromatin organization and remodeling, is localized in the nucleus, and is widely expressed across many tissue types . This distinguishes it from Xin, which is predominantly expressed in muscle tissues and functions in maintaining muscle structure.
Based on validated research protocols, Xin antibodies are suitable for multiple experimental applications:
Western Blot (WB): For detecting Xin protein in tissue lysates
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative measurement of Xin levels
Immunohistochemistry on paraffin-embedded tissues (IHC-P): For visualizing Xin distribution in tissue sections
Immunofluorescence (IF): For cellular localization studies
Immunoprecipitation (IP): For protein-protein interaction studies
The recommended dilution ranges vary by application, with Western Blot typically using a 1:1000 dilution ratio .
To ensure experimental validity when using Xin antibody, researchers should implement the following controls:
Positive control: Include samples known to express Xin (heart or skeletal muscle tissue)
Negative control: Include samples known not to express Xin or use XIRP1 knockout models
Secondary antibody-only control: To assess non-specific binding
Loading control: When performing Western blots, include housekeeping proteins (e.g., GAPDH, actin)
Peptide competition assay: To verify antibody specificity by pre-incubating with the immunizing peptide
Cross-reactivity assessment: Test against related proteins to ensure specificity
These controls help validate experimental findings and distinguish true signal from background noise or non-specific binding.
For optimal results with Xin antibody detection, sample preparation should follow these guidelines:
For Western Blot:
Tissue samples should be homogenized in buffer containing protease inhibitors
For cardiac and skeletal muscle tissues, use specialized extraction buffers that effectively solubilize membrane-associated proteins
Include phosphatase inhibitors if studying phosphorylated forms of Xin (such as phospho-Ser295)
For Immunohistochemistry:
Fixation: Use 10% neutral buffered formalin
Antigen retrieval: Heat-mediated retrieval in citrate buffer (pH 6.0) typically yields optimal results
Blocking: 5% normal serum from the same species as the secondary antibody
Storage conditions for Xin antibody:
Store at -20°C for up to 1 year from the date of receipt
Avoid repeated freeze-thaw cycles
Optimal storage buffer includes 10 mM HEPES (pH 7.5), 150 mM NaCl, 100 µg per ml BSA, and 50% Glycerol
Xin antibody has significant applications in studying cardiac pathologies through multiple approaches:
Comparative expression analysis: Quantify Xin expression levels in normal versus diseased cardiac tissue using Western blot and immunohistochemistry to assess correlation with disease progression.
Localization studies: Track changes in Xin localization at intercalated disks during cardiac remodeling using confocal microscopy with co-staining for other junction proteins.
Phosphorylation status: Use phospho-specific Xin antibodies (such as anti-XIRP1-Ser295) to investigate post-translational modifications that may regulate Xin function during cardiac stress .
Protein-protein interactions: Employ co-immunoprecipitation with Xin antibody to identify binding partners that may be altered in cardiomyopathies.
Time-course studies: Monitor Xin expression and localization during disease progression to establish its role as a potential biomarker for cardiac pathologies.
These approaches allow researchers to elucidate the role of Xin in maintaining cardiac structure and its potential contribution to heart disease mechanisms.
Advanced research approaches combining Xin antibody detection with functional assays include:
Correlative microscopy: Combining immunofluorescence using Xin antibody with live cell imaging or electron microscopy to correlate protein localization with ultrastructural features of muscle cells.
FRAP (Fluorescence Recovery After Photobleaching): Using fluorescently labeled Xin antibody fragments to study the dynamics of Xin-associated complexes in living cells.
Mechanical stress assays: Applying controlled mechanical forces to cultured cardiomyocytes or skeletal muscle cells while monitoring Xin distribution and phosphorylation status to understand its role in mechanotransduction.
Ex vivo tissue function assessment: Correlating contractile properties of isolated muscle preparations with Xin expression and localization patterns determined by immunohistochemistry.
Single-cell proteomics: Combining laser capture microdissection with Xin antibody-based detection to analyze protein expression in specific regions of muscle tissue with distinct functional properties.
These integrated approaches provide deeper insights into the relationship between Xin expression, localization, and muscle functional properties.
Phospho-specific antibodies, such as anti-XIRP1-Ser295, offer unique opportunities to study signaling mechanisms:
Kinase pathway identification: By tracking specific phosphorylation events on Xin using phospho-specific antibodies, researchers can identify the upstream kinases responsible for these modifications.
Temporal regulation analysis: Time-course studies following muscle contraction or stress can reveal when specific phosphorylation events occur, helping to place Xin in signaling cascades.
Pharmacological intervention studies: Using kinase inhibitors in combination with phospho-specific Xin antibody detection can validate signaling pathways and their effects on Xin function.
Multi-site phosphorylation mapping: Different phospho-specific antibodies against various Xin phosphorylation sites can reveal complex regulation patterns and potential hierarchy of phosphorylation events.
Structure-function correlation: Combining phospho-specific antibody detection with functional assays can reveal how specific phosphorylation events alter Xin's interaction with actin filaments and other binding partners .
These approaches collectively advance our understanding of how Xin function is regulated in response to various physiological and pathological stimuli.
Researchers frequently encounter these challenges when working with Xin antibody:
To ensure Xin antibody specificity, implement these validation strategies:
Genetic approaches:
Test antibody in XIRP1 knockout or knockdown models
Compare staining patterns in tissues known to express or lack Xin
Biochemical approaches:
Orthogonal methods:
Correlate protein detection with mRNA expression by qPCR
Use multiple antibodies targeting different epitopes of Xin
Compare with tagged-Xin overexpression systems
Reproducibility assessment:
Test across different lots of the same antibody
Validate across different experimental systems
Compare results with published literature
Proper validation ensures that experimental findings reflect true Xin biology rather than artifacts.
When interpreting differential Xin expression across tissues, consider these analytical frameworks:
Developmental context: Xin expression may vary during muscle development, with highest expression during myofibrillogenesis and at mature intercalated disks .
Functional specialization: Different muscle types (cardiac vs. skeletal) and even different regions within these muscles may require varying levels of Xin for proper function.
Isoform-specific expression: The three identified isoforms of human Xin may have tissue-specific distribution patterns, potentially detected differently by various antibodies.
Pathological alterations: Changes in Xin expression or localization may represent compensatory mechanisms or primary pathological events in muscle diseases.
Technical considerations: Variation in tissue fixation, antibody penetration, and protein extraction efficiency may contribute to apparent differences in expression.
Quantitative analysis: Use digital image analysis and proper normalization when comparing expression levels between tissues to account for background and non-specific staining.
Careful consideration of these factors allows for accurate interpretation of Xin expression patterns in physiological and pathological contexts.
Current research utilizing Xin antibody is advancing cardiac disease understanding through several approaches:
Cardiomyopathy biomarker research: Studies are investigating whether altered Xin expression or localization correlates with specific types of cardiomyopathy, particularly those affecting intercalated disks.
Mechanical stress response: Researchers are examining how Xin phosphorylation patterns (detected with phospho-specific antibodies like anti-XIRP1-Ser295) change during mechanical stress, potentially contributing to pathological cardiac remodeling .
Heart failure progression: Longitudinal studies are tracking Xin expression and localization changes during heart failure development to identify critical transition points.
Regenerative medicine applications: Xin antibody is being used to monitor cardiac differentiation in stem cell-derived cardiomyocytes, helping optimize protocols for regenerative therapies.
Genetic cardiomyopathy models: In models with mutations affecting intercalated disk proteins, Xin antibody helps visualize secondary structural changes that may contribute to disease progression.
These applications collectively enhance our understanding of Xin's role in maintaining cardiac health and its potential as a therapeutic target.
Cutting-edge imaging applications utilizing Xin antibody include:
Super-resolution microscopy: Techniques like STORM and PALM combined with Xin antibody detection allow visualization of intercalated disk nanoscale architecture beyond the diffraction limit.
Intravital imaging: Using minimally invasive fluorescently-labeled Xin antibody fragments to visualize dynamic changes in Xin distribution in living cardiac tissue.
Correlative light and electron microscopy (CLEM): Combining Xin immunolabeling with electron microscopy to correlate protein localization with ultrastructural features at intercalated disks.
Expansion microscopy: Physical expansion of tissue samples labeled with Xin antibody allows visualization of submicroscopic details of the cardiac intercalated disk.
Multiplexed imaging: Simultaneous detection of Xin along with other intercalated disk proteins through multiplexed antibody labeling and spectral unmixing techniques.
4D imaging: Time-lapse confocal microscopy of Xin-labeled structures during cardiac development or in response to pathological stimuli.
These advanced imaging approaches provide unprecedented insights into Xin's dynamic behavior and structural roles.
Innovative antibody engineering strategies that could advance Xin research include:
Single-domain antibodies (nanobodies): Developing smaller antibody fragments against Xin would enable better tissue penetration and higher resolution imaging .
Bispecific antibodies: Creating antibodies that simultaneously recognize Xin and its binding partners would facilitate studies of protein-protein interactions at intercalated disks.
Conformation-specific antibodies: Developing antibodies that specifically recognize active versus inactive conformations of Xin could reveal regulatory mechanisms.
Intrabodies: Expressing antibody fragments intracellularly could enable live-cell visualization of Xin dynamics without fixation artifacts.
Photoswitchable antibodies: Conjugating Xin antibodies with photoswitchable fluorophores would enable super-resolution microscopy with higher precision.
Antibody-drug conjugates for research: While typically used therapeutically, ADC approaches could be adapted to selectively manipulate cells expressing Xin in research models .
These engineering approaches could significantly enhance the toolkit available for studying Xin biology and pathology in increasingly sophisticated ways.